The European Medicines Agency (EMA) is expected to approve the Johnson & Johnson vaccine in early March, after which it is expected to be distributed in late March or early April, French Industry Minister Agnès Pannier-Runacher said on Sunday.
The European Union’s green light should come “in early March as the EMA reviews all the data sent to it by Johnson & Johnson so it can put that vaccine on the market,” Pannier-Runacher told France 3 television.
The first doses should “come in late March, early April because there is a deadline for dose production,” and that is “still being discussed with the lab,” she said.
"This is very good news because this vaccine requires only one dose, but it is possible that vaccine boosters will be needed, but we don't know that yet," she said.
The United States on Saturday approved a single-dose vaccine against Covid-19 by Johnson & Johnson for people over 18 years of age.
European Commission President Ursula von der Leyen said on Thursday that she was "optimistic" about her goal of vaccinating 70 percent of the EU's adult population, or about 225 million people, by the end of the summer, thanks to an expected increase in vaccine deliveries.